<Suppliers Price>

Triphenylmethanamine

Names

[ CAS No. ]:
5824-40-8

[ Name ]:
Triphenylmethanamine

[Synonym ]:
Methylamine, 1,1,1-triphenyl-
Aminotriphenylmethane
Aminotrityl polystyrene resin
Benzenemethanamine, α,α-diphenyl-
1,1,1-Triphenylmethanamine
Tritylamine
Triphenylmethylamine
Aminotrityl,polymer-bound
MFCD00008047

Chemical & Physical Properties

[ Density]:
1.1±0.1 g/cm3

[ Boiling Point ]:
369.3±0.0 °C at 760 mmHg

[ Melting Point ]:
102-104 °C(lit.)

[ Molecular Formula ]:
C19H17N

[ Molecular Weight ]:
259.345

[ Flash Point ]:
190.9±12.3 °C

[ Exact Mass ]:
259.136108

[ PSA ]:
26.02000

[ LogP ]:
4.64

[ Vapour Pressure ]:
0.0±0.8 mmHg at 25°C

[ Index of Refraction ]:
1.620

MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xi:Irritant;

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S26-S36-S37/39

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ HS Code ]:
2921499090

Synthetic Route

Precursor & DownStream

Customs

[ HS Code ]: 2921499090

[ Summary ]:
2921499090 other aromatic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

Articles

Structure-activity relationship of S-trityl-L-cysteine analogues as inhibitors of the human mitotic kinesin Eg5.

J. Med. Chem. 51 , 1115-25, (2008)

The human kinesin Eg5 is a potential drug target for cancer chemotherapy. Eg5 specific inhibitors cause cells to block in mitosis with a characteristic monoastral spindle phenotype. Prolonged metaphas...

Triarylmethanes, a new class of cx50 inhibitors.

Front. Pharmacol. 3 , 106, (2012)

The paucity of specific pharmacological agents has been a major impediment for delineating the roles of gap junction (GJ) channels formed by connexin proteins in physiology and pathophysiology. Here, ...

Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.

J. Med. Chem. 51 , 976-82, (2008)

Sickle cell disease (SCD) is a hereditary condition characterized by deformation of red blood cells (RBCs). This phenomenon is due to the presence of abnormal hemoglobin that polymerizes upon deoxygen...


More Articles


Related Compounds